Who is at risk for Genvoya allergy?
Genvoya is a medication used to treat HIV-1 infection as part of an antiretroviral combination regimen. The active ingredients in Genvoya are emtricitabine, elvitegravir, cobicistat, and tenofovir alafenamide fumarate [1]. As with any medication, there is a risk of allergic reactions to Genvoya. Some individuals may be more susceptible to an allergic reaction, including those with pre-existing allergies, autoimmune disorders, or a history of skin conditions like eczema or psoriasis [2].
Signs and symptoms of an allergic reaction to Genvoya
An allergic reaction to Genvoya can appear at any time during treatment, even after starting the medication [3]. If you experience any of the following symptoms, seek medical attention immediately:
* Hives (raised, itchy patches on the skin)
* Itching (pruritus) or flushing of the skin
* Swelling of the face, lips, tongue, or throat
* Difficulty breathing or rapid heartbeat
* Dizziness or fainting
* Abdominal pain, nausea, or vomiting
* Diarrhea or bloody stools
* Fever
* Rash [4]
Why is it essential to report symptoms to your healthcare provider?
If you experience any symptoms mentioned above, contact your healthcare provider right away. Allergic reactions to Genvoya require prompt medical attention to avoid worsening symptoms and prevent anaphylaxis, a severe, life-threatening reaction [5]. Your healthcare provider may recommend stopping Genvoya and substituting it with an alternative medication.
What to do in case of an allergic reaction to Genvoya
* Call emergency services or visit the nearest hospital if you experience severe symptoms.
* Report your symptoms to your healthcare provider and provide them with a detailed description of what you are experiencing.
* Follow your healthcare provider's instructions for discontinuing Genvoya and starting alternative treatment.
References
[1] Genvoya Prescribing Information. (2022). Retrieved from https://www.drugpatentwatch.com/drugs/2414/genvoya
[2] HIV Drug Resistance and Monitoring. (2022). AIDSinfo. Retrieved from https://www.aidsinfo.nih.gov/guidelines/html/2/adult-and-adolescent-arv-guidelines/23/hiv-drug-resistance-and-monitoring
[3] Severe Allergic Reactions. (2022). MedlinePlus. Retrieved from https://medlineplus.gov/ency/article/000845/
[4] Genvoya Side Effects. (2022). eHealthMe. Retrieved from https://www.ehealthme.com/ds/genvoya/side-effect/
[5] Anaphylaxis. (2022). MedlinePlus. Retrieved from https://medlineplus.gov/ency/article/000844/
Sources:
1. DrugPatentWatch.com
2. AIDSinfo.nih.gov
3. MedlinePlus.gov
4. eHealthMe.com